alexa Next-generation proteomics: towards an integrative view of proteome dynamics.
Bioinformatics & Systems Biology

Bioinformatics & Systems Biology

Journal of Proteomics & Bioinformatics

Author(s): Altelaar AF, Munoz J, Heck AJ

Abstract Share this page

Abstract Next-generation sequencing allows the analysis of genomes, including those representing disease states. However, the causes of most disorders are multifactorial, and systems-level approaches, including the analysis of proteomes, are required for a more comprehensive understanding. The proteome is extremely multifaceted owing to splicing and protein modifications, and this is further amplified by the interconnectivity of proteins into complexes and signalling networks that are highly divergent in time and space. Proteome analysis heavily relies on mass spectrometry (MS). MS-based proteomics is starting to mature and to deliver through a combination of developments in instrumentation, sample preparation and computational analysis. Here we describe this emerging next generation of proteomics and highlight recent applications. This article was published in Nat Rev Genet and referenced in Journal of Proteomics & Bioinformatics

Relevant Expert PPTs

Relevant Speaker PPTs

  • Dwi Astuti
    Phylogenetic position of Psittacula parakeet bird from Enggano Island, Indonesia based on analyses of cytochrome b gene sequences
    PPT Version | PDF Version
  • Francis Jeshira Reynoso
    The clinical phenotype of PIGN deficiency and consequences of defective GPI biogenesis
    PPT Version | PDF Version
  • Yosef Yarden
    Classically, the 3’untranslated region (3’UTR) is that region in eukaryotic protein-coding genes from the translation termination codon to the polyA signal. It is transcribed as an integral part of the mRNA encoded by the gene. However, there exists another kind of RNA, which consists of the 3’UTR alone, without all other elements in mRNA such as 5’UTR and coding region. The importance of independent 3’UTR RNA (referred as I3’UTR) was prompted by results of artificially introducing such RNA species into malignant mammalian cells. Since 1991, we found that the middle part of the 3’UTR of the human nuclear factor for interleukin-6 (NF-IL6) or C/EBP gene exerted tumor suppression effect in vivo. Our subsequent studies showed that transfection of C/EBP 3’UTR led to down-regulation of several genes favorable for malignancy and to up-regulation of some genes favorable for phenotypic reversion. Also, it was shown that the sequences near the termini of the C/EBP 3’UTR were important for its tumor suppression activity. Then, the C/EBP 3’UTR was found to directly inhibit the phosphorylation activity of protein kinase CPKC in SMMC-7721, a hepatocarcinoma cell line. Recently, an AU-rich region in the C/EBP 3’UTR was found also to be responsible for its tumor suppression. Recently we have also found evidence that the independent C/EBP 3’UTR RNA is actually exists in human tissues, such as fetal liver and heart, pregnant uterus, senescent fibroblasts etc. Through 1990’s to 2000’s, world scientists found several 3’UTR RNAs that functioned as artificial independent RNAs in cancer cells and resulted in tumor suppression. Interestingly, majority of genes for these RNAs have promoter-like structures in their 3’UTR regions, although the existence of their transcribed products as independent 3’UTR RNAs is still to be confirmed. Our studies indicate that the independent 3’UTR RNA is a novel non-coding RNA species whose function should be the regulation not of the expression of their original mRNA, but of some essential life activities of the cell as a whole.
    PPT Version | PDF Version
  • Nwankwo Norbert Ikechukwu
    Direct computerized translation of biological data into biological information is now feasible: The gains of digital signal processing-based bioinformatics techniques
    PPT Version | PDF Version
  • Soo-Young Yoon
    Isocitrate dehydrogenase 1 (IDH1) mutation-specific twelve microRNA signatures as prognostic biomarkers in acute myeloid leukemia
    PPT Version | PDF Version
  • Tamar Geiger
    Genome-Scale Proteomic Profiling of Breast Cancer Progression
    PPT Version | PDF Version
  • Hehuang Xie
    Decoding epigenome with integrative omics data analysis
    PPT Version | PDF Version
  • Asad U Khan
    Inhibitors against Resistant markers: a Molecular and computational Biology approach
    PPT Version | PDF Version
  • M.Krishnan
    Molecular cloning, expression, purification and functional characterization of 37 kDa Serine Protease from Bombyx mori
    PPT Version | PDF Version
  • Steven M Carr
    Novel quantitative analyses of phylogeographic structure and connectivity among marine populations as inferred from whole-genome mtDNA sequences
    PPT Version | PDF Version
  • Nadia El Kadmiri
    Proteomics aspects of Morrocan cases with Alzheimer’s Disease.
    PPT Version | PDF Version
  • Sevgi Gezici
    Application of Nanobiotechnology in Oncoproteomics
    PPT Version | PDF Version
  • Dharani Das
    Toxicity Evaluation of Carbon Nanotubes in J774 Mouse Macrophages Utilizing a Proteomic Approach
    PPT Version | PDF Version
  • Fuad Fares
    The role of oligosaccharides on structure and function of glycoprotein hormones: developing of agonists and antagonists
    PPT Version | PDF Version
  • AlAjmi, Mohamed F
    Role of Supervised pattern recognition in medicinal plants identification
    PPT Version | PDF Version

Recommended Conferences

  • 9th International Conference on Bioinformatics
    October 23-24, 2017 Paris, France
  • 9th International Conference and Expo on Proteomics
    October 23-25, 2017 Paris, France

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords